Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what progress his Department has made in delivering the 250,000 doses of the Mpox vaccine for the 125,000 people deemed to be in priority groups for that vaccine.

To date, the UK Health Security Agency (UKHSA) has procured over 150,000 vials of the mpox vaccine. The adoption of intradermal fractional dosing has allowed up to five doses to be administered per vial, which has furthered available stock.

The estimated group size of individuals at highest risk of mpox and therefore eligible for vaccination is 111,000. As of 18 January 2023, in England, a total of 64,740 people have received their first dose of mpox vaccine and 20,373 people have come forward for their second dose. The rollout of the mpox vaccination campaign has, in combination with other factors, contributed to the marked decline in cases.

UKHSA has also launched an Mpox and Sexual Health Outreach and Engagement Fund to support these efforts.